Adaptive baroreflex stimulation therapy for disordered breathing

• US 8,442,638 B2
• Filed: 05/17/2010
• Issued: 05/14/2013
• Est. Priority Date: 06/08/2004
• Status: Expired due to Fees

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Libbus, Imad, Ni, Quan, Lee, Kent
• Primary Examiner(s): Koharski, Christopher D
• Assistant Examiner(s): Patel, Natasha
• Application Number:
  US12/781,447
• Publication Number:
  US 20100228317A1
• Time in Patent Office: 1,093 Days
• Field of Search: 607/20, 607/42, 607/134
• US Class Current: 607/42
• CPC Class Codes: A61N 1/3601 of respiratory organs
• CPC Class Codes: A61N 1/3611 Respiration control stimulating respiratory organs A61N1/3601
• CPC Class Codes: A61N 1/3614 based on impedance measurement

Abstract

An approach to providing disordered breathing therapy includes delivering electrical stimulation therapy modifying a patient'"'"'s baroreflex response. Disordered breathing therapy may be delivered in response to prediction or detection of disordered breathing events. Various conditions affecting the patient may be evaluated and the baroreflex therapy modified. The therapy may be modified to improve therapy efficacy, to reduce an impact to the patient and/or to mitigate therapy interactions.

Claims

1. A method of providing disordered breathing therapy to a patient, comprising:

sensing one or more conditions affecting the patient;

predicting disordered breathing or detecting disordered breathing in the patient using the one or more of the sensed conditions; and

in response to predicting or detecting, delivering a first disordered breathing therapy and a second disordered breathing therapy and implementing instructions in a programmed therapy controller to coordinate the delivery of the first and second disordered breathing therapies, wherein the first disordered breathing therapy includes an electrical stimulation of a neural target to modify a baroreflex response and the second disordered breathing therapy does not include the electrical stimulation of the neural target to modify the baroreflex response, wherein implementing instructions in a programmed therapy controller to coordinate the delivery of the first and second disordered breathing therapies includes using the programmed therapy controller to evaluate the one or more conditions affecting the patient after delivering the first disordered breathing therapy and the second disordered breathing therapy and to adapt the first and second desired breathing therapies.

2. The method of claim 1,

wherein using the programmed therapy controller to adapt the first and second disordered breathing therapies includes using the programmed therapy controller to adapt the first and second disordered breathing therapies to improve efficacy.

3. The method of claim 1,

wherein using the programmed therapy controller to adapt the first and second disordered breathing therapies includes using the programmed therapy controller to adapt the first and second disordered breathing therapies to reduce impact to the patient.

4. The method of claim 1,

wherein using the programmed therapy controller to adapt the first and second disordered breathing therapies includes using the programmed therapy controller to adapt the first and second disordered breathing therapies to reduce or avoid therapy interaction.

5. The method of claim 1, further comprising:

classifying the predicted or detected disordered breathing;

delivering the first disordered breathing therapy and not delivering the second disordered breathing therapy if the predicted or detected disordered breathing is classified as a first type; and

delivering the second disordered breathing therapy and not delivering the first disordered breathing therapy if the predicted or detected disordered breathing is classified as a second type.

6. The method of claim 1, wherein the second disordered breathing therapy includes cardiac electrical stimulation.

7. The method of claim 6, wherein the cardiac electrical stimulation includes overdrive pacing.

8. The method of claim 1, wherein the second disordered breathing therapy includes electrical stimulation of a hypoglossal nerve, wherein the hypoglossal nerve innervates protrusor and retractor tongue muscles.

9. The method of claim 1, wherein the second disordered breathing therapy includes positive airway pressure therapy.

10. The method of claim 1, wherein the second disordered breathing therapy includes electrical stimulation of a phrenic nerve.

11. The method of claim 1, wherein the sensed one or more conditions includes predisposing conditions that are statistically associated with an onset of disordered breathing.

12. The method of claim 1, wherein the sensed one or more conditions includes precursor conditions that indicate an impending onset of disordered breathing.

13. The method of claim 1, wherein the sensed one or more conditions includes conditions used to verify a prediction of disordered breathing.

14. A system to provide disordered breathing therapy to a patient, comprising:

a sensing system configured to sense one or more conditions affecting the patient;

a disordered breathing predictor coupled to the sensing system and configured to evaluate the one or more conditions to predict disordered breathing;

a first disordered breathing therapy device configured to deliver electrical neural stimulation to a neural target to modulate a baroreflex response of the patient;

a second disordered breathing therapy device configured to deliver a therapy that does not deliver electrical neural stimulation to the neural target to modulate the baroreflex response of the patient; and

a therapy controller coupled to the first and second therapy devices and configured to coordinate delivery of the first and second disordered breathing therapies, wherein the therapy controller is configured to evaluate the one or more conditions affecting the patient after delivering the first disordered breathing therapy and the second disordered breathing therapy, and adapt the first and second disordered breathing therapies to improve efficacy, to reduce impact to the patient, or to reduce or avoid therapy interaction.

15. The system of claim 14, wherein the second disordered breathing therapy device is configured to deliver cardiac electrical stimulation.

16. The system of claim 15, wherein the second disordered breathing therapy device is configured to deliver overdrive pacing to a cardiac chamber.

17. The system of claim 14, wherein the second disordered breathing therapy device is configured to deliver electrical stimulation to a hypoglossal nerve, wherein the hypoglossal nerve innervates protrusor and retractor tongue muscles.

18. The system of claim 14, wherein the second disordered breathing therapy device is configured to deliver positive airway pressure therapy.

19. The system of claim 14, wherein the second disordered breathing therapy device is configured to deliver electrical stimulation of a phrenic nerve.

20. The system of claim 14, wherein the disordered breathing predictor is configured to use the sensed one or more conditions to determine that the patient is predisposed for an onset of disordered breathing.

21. The system of claim 14, wherein the disordered breathing predictor is configured to use the sensed one or more conditions to determine that an onset of disordered breathing is impending.

22. The system of claim 14, wherein the disordered breathing predictor is configured to the sensed one or more conditions to verify a predication of disordered breathing.